Biotech · Private company
AvenCell Therapeutics, Inc.
Track this companyFree. Adds AvenCell Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Allo-QuadCAR01-TPhase 2 · Lymphoma Diffuse Large B-cellClinicalTrials.gov · fetched Nov 12, 2026
- Cyclophosphamide (Non-IMP, Lymphodepletion)Phase 2 · Lymphoma Diffuse Large B-cellClinicalTrials.gov · fetched Nov 12, 2026
- Fludarabine (Non-IMP, Lymphodepletion)Phase 2 · Lymphoma Diffuse Large B-cellClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell MalignanciesPHASE1_PHASE2 · RECRUITING · started Jan 6, 2026ClinicalTrials.gov NCT07284433 · fetched Nov 12, 2026